2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcgammaRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.
CAS Nummer:
[2923542-55-4]
Target-Kategorie:
TNF
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten